|
|
Thomson Financial Business Description:
| The Group's principal activity is to develop, manufacture and market innovative systems for the treatment of renel disease, ESRD and acute kidney failure. The Group's products include NxStage System One. NxStage System One is a portable easy-to-use hemodialysis system designed to provide physicians and patients improved flexibility in how hemodialysis therapy is prescribed and delivered. The Group's trademarks are Nxstage and Nxstage logo. The Group sells its products to two markets: the chronic market and the critical care market. As of 31-Dec- 2007, 2,223 ESRD patientsand 115 hospitals were using the System One at 334 different dialysis clinics. The Group operates in the United States. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on NxStage Medical, Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
